You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor heterogeneity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Using Genomic, Histologic and Radiomic Analysis to Evaluate

Suspended
  • Glioblastoma
  • Tumor Biopsy
  • Ann Arbor, Michigan
    University of Michigan
Oct 6, 2022

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
    • Copenhagen, Denmark
      Department of Hematology, Rigshospitalet
    Jan 12, 2022

    Ovarian Cancer Trial in Vandœuvre-lès-Nancy (Diagnostic Test)

    Recruiting
    • Ovarian Cancer
    • Diagnostic Test
    • Vandœuvre-lès-Nancy, France
      Institut de Cancerologie de Lorraine
    Mar 29, 2022

    Donation of Post Mortem Tumor Tissues

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Proteomic analysis
    • Milano, Italy
      ASST GOM Niguarda
    Aug 16, 2021

    NSCLC, PET/CT, Biopsy Trial in XiaMen (18F-FDG PET/CT and PET/CT-guide targeted biopsy in another group of participants)

    Unknown status
    • NSCLC
    • +5 more
    • 18F-FDG PET/CT and PET/CT-guide targeted biopsy in another group of participants
    • XiaMen, Fujian, China
      First affiliated hospital of xiamen university
    Sep 11, 2020

    Immunological Heterogeneity of Tumor Microenvironment in

    Recruiting
    • Stomach Cancer
      • Fuzhou, Fujian, China
        Department of Gastric Surgery
      Apr 12, 2021

      Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

      Completed
      • Glioma
        • Montpellier, France
          Uh Montpellier
        Jun 4, 2020

        Cervical Cancer, Uterine Cervical Cancer, Uterine Cervical Tumors Trial in Saint Louis (FDG-PET/MR, FDG-PET/CT)

        Terminated
        • Cervical Cancer
        • +2 more
        • FDG-PET/MR
        • FDG-PET/CT
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jun 8, 2020

        Patient-derived Glioma Stem Cell Organoids

        Active, not recruiting
        • Glioblastoma
        • Tumor biopsy
        • Maastricht, Limburg, Netherlands
        • +1 more
        Apr 29, 2021

        Ovarian Cancer Trial in Harrison, New York (PET/CT Scan, MRI)

        Completed
        • Ovarian Cancer
        • PET/CT Scan
        • MRI
        • Harrison, New York
        • +1 more
        Jun 17, 2020

        Pancreatic Cancer, Resectable Pancreatic Cancer Trial in Tampa (Pimonidazole, Surgical Resection)

        Withdrawn
        • Pancreatic Cancer
        • Resectable Pancreatic Cancer
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Feb 3, 2021

        HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

        Active, not recruiting
        Has Results
        • HER-2 Positive Breast Cancer
        • +3 more
        • Boston, Massachusetts
        • +3 more
        Mar 4, 2022

        Pancreas Cancer Trial in Montpellier (Biological/Vaccine: Blood sample and tissue sample)

        Not yet recruiting
        • Pancreas Cancer
        • Biological/Vaccine: Blood sample and tissue sample
        • Montpellier, France
          NOUGARET Stephanie
        Nov 23, 2023

        High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

        Not yet recruiting
        • High Grade Serous Ovarian Cancer
        • Blood sample and tissue sample
        • Montpellier, France
          NOUGARET Stephanie
        Oct 10, 2023

        Multi-Dimensional MRI Spatial Heterogeneity Analysis for

        Not yet recruiting
        • High-grade Glioma
        • MR scanning; Clinical data collection
        • Shanghai, Shanghai, China
          Department of Radiology, Renji hospital, School of Medicine, Sha
        Aug 16, 2023

        Microenvironment of Lung Cancer and Exploration of Mechanism of

        Recruiting
        • Lung Cancer
        • Multiomics analysis
        • Yiwu, Zhejiang, China
          The Fourth Affiliated Hospital of Zhejiang University
        Dec 16, 2022

        HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

        Not yet recruiting
        • HER2 Positive Advanced Solid Tumors
        • HypoSti.CAR-HER2 T cells
        • +2 more
        • (no location specified)
        Jan 12, 2023

        Molecular Heterogeneity in Multilobar Low-grade Gliomas

        Unknown status
        • Low-grade Diffuse Glioma
        • sequencing of the complete exome
        • Montpellier, France
          CHU Gui de Chauliac
        Dec 2, 2019

        Rhabdoid Tumors Cellular Architecture by Single-cell Analyses

        Recruiting
        • ATRT
        • analyzes in singles cells
        • Paris, France
          Institut Curie
        Apr 4, 2022

        Circulating Tumor DNA in Surgical Patients With Lung Cancer

        Active, not recruiting
        • Lung Cancer
          • Chengdu, Sichuan, China
            West China Hospital, Sichuan University
          Oct 12, 2022

          Breast Cancer Trial in Shanghai (Ultrasound-guided core needle biopsy in breast)

          Completed
          • Breast Cancer
          • Ultrasound-guided core needle biopsy in breast
          • Shanghai, Shanghai, China
            Zhi-Min Shao
          Dec 14, 2022

          Rapid Autopsy and Procurement of Cancer Tissue

          Recruiting
          • Thymus Tumors
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 20, 2022

            Circulating DNA in Surgically Treated NSCLC

            Unknown status
            • Non-small Cell Lung Cancer
            • Circulating tumor DNA
            • Helsinki, Uusimaa, Finland
              Helsinki University Central Hospital
            Aug 2, 2019

            Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))

            Not yet recruiting
            • Lung Cancer
            • Biopsy (baseline)
            • +2 more
            • Shanghai, China
              Shanghai Pulmonary Hospital
            May 11, 2023

            Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)

            Active, not recruiting
            • Glioma, Malignant
            • Computer-Assisted
            • Validation of IDH1 mutations from the radiomics model
            • Shanghai, Shanghai, China
              Huashan Hospital, Fudan University
            Jul 23, 2023